Life Changing Daily Pill that Fights Cancer and Autoimmune Diseases
Invest Now for a Limited Time
About
Technology
Pipeline
Media
News
Publications
Investors
Contact Us
Trethera
News & Publications
Trethera
Latest News
Trethera Receives $1.8 Million NIH Grant to Advance TRE-515 Development for Crohn’s Disease
Read More
Trethera Successfully Completes Enrollment of Phase 1 Dose Escalation Trial for Patients with Solid Tumors
Read More
Trethera Awarded $2.3 Million NIH Grant to Study TRE-515 Combined with Radiation Therapy in Prostate Cancer Preclinical Models
Read More
Trethera Awarded $3 Million NIH Grant to Advance First-In-Class Drug, TRE-515, for the Treatment of Lupus
Read More
FDA Provides Trethera Clearance to Initiate TRE-515 Clinical Trial in Healthy Volunteers to Study Food Effect and Biomarkers
Read More
FDA Grants Fast Track Designation for TRE-515 in Combination with Radiation Therapy for the Treatment of Metastatic Castration Resistant Prostate Cancer
Read More
Views More News
Trethera
Latest Publications
Targeting Deoxycytidine Kinase Improves Symptoms in Mouse Models of Multiple Sclerosis
Read More
18F-FAC PET Visualizes Brain-Infiltrating Leukocytes in a Mouse Model of Multiple Sclerosis
Read More
Structure-Guided Development of Deoxycytidine Kinase Inhibitors with Nanomolar Affinity and Improved Metabolic Stability
Read More
Deoxycytidine Kinase Augments ATM-Mediated DNA Repair and Contributes to Radiation Resistance
Read More
Nucleoside salvage pathway kinases regulate hematopoiesis by linking nucleotide metabolism with replication stress
Read More
Novel Positron Emission Tomography Probes Specific for Deoxycytidine Kinase
Read More
Views More Publications